Genomic structure of the human KDR/flk-1 gene

被引：11
|
作者：
Yin, LY [1 ]
Wu, YX [1 ]
Ballinger, CA [1 ]
Patterson, C [1 ]
机构：
[1] Univ Texas, Med Branch, Div Cardiol, Galveston, TX 77555 USA
来源：
MAMMALIAN GENOME | 1998年 / 9卷 / 05期
关键词：
D O I：
10.1007/s003359900783
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：408 / 410
页数：3
相关论文
共 50 条
  • [21] Type 2 VEGF receptor (Flk-1/KDR), recruits IRS-1 in its signaling pathway
    Duraisamy, S
    Choudhury, GG
    Kasinath, BS
    DIABETES, 2002, 51 : A454 - A454
  • [22] Endothelial cells pretreated with high glucose enhanced the expression of Flk-1/Kdr and angiogenesis induced by VEGF
    Onodera, M
    Morita, I
    Nagai, R
    Horiuchi, S
    Itoh, H
    Murota, S
    ATHEROSCLEROSIS, 1999, 144 : 66 - 66
  • [23] Flk-1/KDR Mediates Ethanol-Stimulated Endothelial Cell Notch Signaling and Angiogenic Activity
    Morrow, David
    Hatch, Ekaterina
    Hamm, Katie
    Cahill, Paul A.
    Redmond, Eileen M.
    JOURNAL OF VASCULAR RESEARCH, 2014, 51 (04) : 315 - 324
  • [24] CONSTITUTIVE EXPRESSION OF THE VEGF RECEPTOR KDR/FLK-1 IN CORNEAL ENDOTHELIAL-CELL MEDIATES THEIR PROLIFERATION
    ORTEGA, N
    PLOUET, J
    VISION RESEARCH, 1995, 35 : 4217 - 4217
  • [25] Expression of vascular endothelial growth factor and its receptor, KDR/Flk-1, in soft tissue sarcomas
    Pakos, EE
    Goussia, AC
    Tsekeris, PG
    Papachristou, DJ
    Stefanou, D
    Agnantis, NJ
    ANTICANCER RESEARCH, 2005, 25 (05) : 3591 - 3596
  • [26] Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway
    Jeong, SJ
    Itokawa, T
    Shibuya, M
    Kuwano, M
    Ono, M
    Higuchi, R
    Miyamoto, T
    CANCER LETTERS, 2002, 187 (1-2) : 129 - 133
  • [27] Transforming growth factor-β1-mediated inhibition of the flk-1/KDR gene is mediated by a 5′-untranslated region palindromic GATA site
    Minami, T
    Rosenberg, RD
    Aird, WC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) : 5395 - 5402
  • [28] Inhibitory effect of tumor progression and gene expression profiling using GW654652, KDR/Flk-1 tyrosine kinase inhibitor.
    Huh, JI
    Calvo, A
    Stafford, J
    Cheung, M
    Kumar, R
    Gadisetti, C
    Green, JE
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S135 - S135
  • [29] A requirement for FLK-1 in hematopoiesis and vasculogenesis
    Ho, J
    Shalaby, F
    DieterFisher, K
    Bernstein, A
    Rossant, J
    DEVELOPMENTAL BIOLOGY, 1997, 186 (02) : A181 - A181
  • [30] VEGF receptors KDR/Flk-1 and Flt-1 are expressed by distinct cell populations in inflamed synovium.
    Gogarty, M
    Murphy, EP
    Bresnihan, B
    FitzGerald, O
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S568 - S569
12345